Gregory Gambescia % , Author at IBX Insights %

IBX Insights

Scientist filling vials with solution through pipette.

What’s Up with Biosimilars?

For the past few years, health plans have been trying to figure out the best strategies for using biosimilars to help lower how much is spent on specialty drugs and…

Gregory GambesciaOctober 20, 2021

Employers Pharmacy Spotlight

Monitoring the FDA Pipeline

The U.S. Food and Drug Administration (FDA) must approve medications and other therapies as safe and effective before they can be sold in the U.S. Back in the late 1980s,…

Gregory GambesciaAugust 27, 2020

In the foreground, an IV drip, in the background, a blurry patient in a hospital bed.

Employers Pharmacy Spotlight

Lowering Treatment Costs with Preferred Biosimilars

At Independence Blue Cross, we are always striving for innovative ways to make specialty drugs more affordable without restricting member access to the medications they need. As part of these…

Gregory GambesciaJuly 28, 2020

© 2023 Independence Blue Cross
Independence Blue Cross is a subsidiary of Independence Health Group, Inc. — independent licensees of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.
Legal | Privacy Policy

IBX Insights

Gregory Gambescia

What’s Up with Biosimilars?

Monitoring the FDA Pipeline

Lowering Treatment Costs with Preferred Biosimilars

Need Health Insurance?

Eligible for Medicare?

Most Popular Posts